PL141866B1 - Method of obtaining 1,8-dihydroxy-10-ocyl-9-antrones - Google Patents

Method of obtaining 1,8-dihydroxy-10-ocyl-9-antrones Download PDF

Info

Publication number
PL141866B1
PL141866B1 PL1984247724A PL24772484A PL141866B1 PL 141866 B1 PL141866 B1 PL 141866B1 PL 1984247724 A PL1984247724 A PL 1984247724A PL 24772484 A PL24772484 A PL 24772484A PL 141866 B1 PL141866 B1 PL 141866B1
Authority
PL
Poland
Prior art keywords
dihydroxy
formula
anthrone
hours
acid chloride
Prior art date
Application number
PL1984247724A
Other languages
Polish (pl)
Other versions
PL247724A1 (en
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of PL247724A1 publication Critical patent/PL247724A1/en
Publication of PL141866B1 publication Critical patent/PL141866B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

Przedmiotem wynalazku jest opracowanie sposobu, który umozliwia osiagniecie powaznych korzysci. Temperaturereakcji mozna obnizyc do poziomu tak niskiego jak -10°C, a w kazdym razie mozliwe jest zastosowanie bardzo niskiej temperatury reakcji, np. temperatury pokojowej. W dodatku mozna uniknac stosowania benzenu, i stosowac np. toluen, który jest mniej szkodliwy.Ponadto mozna zwiekszyc wydajnosc 2 do 3-krotnie w porównaniu ze sposobem wedlug finskiego opisu patentowego FI nr 57 743.Sposób wytwarzania l,8-dwuhydroksy-10-acylo-9-antronu, o wzorze 1, w którym R oznacza grupe alkilowa o 2-4 atomach wegla, poprzez reakcje 1,8-dwuhydroksy-9-antronu o wzorze 2 z chlorkiem kwasowym o wzorze RCOC1, w którym R ma wyzej podane znaczenie, wedlug wyna¬ lazku polega na tym, ze w mieszaninie reakcyjnej stosuje sie 2,6-dwumetylopirydyne.Jako rozpuszczalnik stosuje sie korzystnie toluen, ksylen albo chlorowane weglowodory takie jak dwuchlorometan albo czterochloroetan.Chlorek kwasowy stosuje sie korzystne w nadmiarze wynoszacym 100%. Temperaturareakcji wynosi -10 do +20°C, chlorek kwasowy dodaje sie w ciagu dwóch godzin, i mieszanie kontynuuje sie w ciagu dalszych dwóch godzin.Wynalazek oparty jest na obserwacji, ze zastapienie pirydyny przez 2,6-dwumetylopirydyne umozliwia obnizenie temperatury reakcji, zastosowanie toluenu, ksylenu albo chlorowanych weg-1 141 866 iowodorów takich jak dwuchlorometan albo czterochloroetan zamiast benzenu, a nawet potrojenie wydajnosci w porównaniu ze znana metoda. Jesli ponadto stosuje sie chlorek kwasowy w nadmia¬ rze wynoszacym 100ct, reakcje mozna zakonczyc w ciagu dwóch godzin.Z wyzej wymienionej niskiej temperatury reakcji, która moze wynosic np. -10°C do+20°C, wynika, ze ilosc zanieczyszczen przechodzacych do wytworzonego l,8-dwuhydroksy-10-acylo-9- antronu jest niewielka. Oczyszczanie jest zatem prostym postepowaniem w porównaniu z odpo¬ wiednia procedura w znanym sposobie. Acetonitryl albo 2-propanol nadaja sie do zastosowania jako rozpuszczalnik do rekrystalizacji razem z kwasem octowym albo zamiast niego.Zwiazki wytworzone sposobem wedlug wynalazku mozna stosowac np. w kremach do skóry na podstawie wazeliny albo parafiny w stezeniu 0,5-5%, w precikach do pielegnacji skóry w stezeniu np. 2-8% i w galaretkach i roztworach tworzacych blonki.Nastepujace przyklady wyjasniaja szczególy wynalazku.P r z y k l a d I. Chlorek butyrylu w ilosci 207 ml (213 ml), 2,0 mole) dodano w ciagu 2 godzin w temperaturze ponizej 0°C do mieszaniny, która zawierala 2500 ml toluenu, 226 g (1,0 mol) 1,8- dwuhydroksy-9-antronu i 232 ml (214 g, 2,0 mole) 2,6-dwumetylopirydyny.Mieszanine mieszano w temperaturze ponizej 0°C w ciagu dalszych dwóch godzin.Mieszanine ogrzano nastepnie do temperatury+40°C, odsaczono chlorowodorek 2,6-dwu¬ metylopirydyny, i wiekszosc toluenu odparowano pod zmniejszonym cisnieniem. Do pozostalosci dodano 2300 ml izopropanolu, mieszanine oziebiono do temperatury -10°C.Otrzymany po przesaczeniu osad poddano rekrystalizacji z acetronitrylu, uzyskujac 222 g l,8-dwuhydroksy-10-butyrylo-9-antronu, 75% wydajnosci teoretycznej.Przykladll. Postepowano analogicznie jak w przykladzie I, z tym, ze zastosowano ksylen zamiast toleunu. Wydajnosc byla taka sama jak w przykladzie I, to jest 75%.Przyklad III. Chlorek propionylu w ilosci 86,9ml (92,5g, 1 mol) dodano w ciagu okolo 2 godzin w temperaturze ponizej 0°C do mieszaniny, która zawierala 1200 ml toluenu, 113g (0,5 moli) l,8-dwuhydroksy-9-antronu i 116ml (107g, 1 mol) 2,6-dwumetylopirydyny. Mieszanie kon¬ tynuowano w ciagu dalszych dwóch godzin po dodaniu.Otrzymany w wyniku l,8-dwuhydroksy-10-propionylo-9-antron oddzielono w sposób przed¬ stawiony w przykladzie I. Wydajnosc wynosila 120g, to znaczy 82% wydajnosci teoretycznej.Przyklad IV. Przy zastosowaniu 1,8-dwuhydroksy-9-antronu i chlorku walerylu uzytym w nadmiarze wynoszacym 100% oraz postepujac jak w przykladzie I, otrzymano 1,8-dwuhydroksy- 10-walerylo-9-antron z wydajnoscia 53%.Zastrzezenia patentowe 1. Sposób wytwarzania l,8-dwuhydroksy-10-acylo-9-antronu, o wzorze 1, w którym R ozna¬ cza grupe alkilowa o 2-4 atomach wegla, poprzez reakcje 1,8-dwuhydroksy-9-antronu o wzorze 2 z chlorkiem kwasowym o wzorze RCOC1, w którym R ma wyzej podane znaczenie, znamienny tym, ze w mieszaninie reakcyjnej stosuje sie 2,6-dwumetylopirydyne. 2. Sposób wedlug zastrz. 1, znamienny tym, ze jako rozpuszczalnik stosuje sie toluen, ksylen albo chlorowane weglowodory takie jak dwuchlorometan albo czterochloroetan. 3. Sposób wedlug zastrz. 1, znamienny tym, ze chlorek kwasowy stosuje sie w nadmiarze wynoszacym 100%. 4. Sposób wedlug zastrz. 1, znamienny tym, ze stosuje sie temperature reakcji -10 do-l-20oC, chlorek kwasowy dodaje sie w ciagu 2 godzin, i mieszanie kontynuuje sie w ciagu nastepnych dwóch godzin.141866 CO-R WZÓR 1 HO O OH WZCfR 2 PL PL PL PL The subject of the invention is to develop a method that allows achieving significant benefits. The reaction temperature can be lowered to as low as -10°C, and in any case it is possible to use a very low reaction temperature, e.g. room temperature. In addition, you can avoid the use of benzene and use, for example, toluene, which is less harmful. Moreover, you can increase the efficiency by 2 to 3 times compared to the method according to the Finnish patent FI No. 57,743. Method for producing 1,8-dihydroxy-10- acyl-9-anthrone, of formula 1, where R is an alkyl group with 2-4 carbon atoms, by reacting 1,8-dihydroxy-9-anthrone of formula 2 with an acid chloride of formula RCOC1, where R has the above The importance of the invention is that 2,6-dimethylpyridine is used in the reaction mixture. Toluene, xylene or chlorinated hydrocarbons such as dichloromethane or tetrachloroethane are preferably used as the solvent. The acid chloride is preferably used in an excess of 100%. The reaction temperature is -10 to +20°C, the acid chloride is added within two hours, and stirring is continued for a further two hours. The invention is based on the observation that replacing pyridine with 2,6-dimethylpyridine makes it possible to lower the reaction temperature, the use toluene, xylene or chlorinated hydrocarbons such as dichloromethane or tetrachloroethane instead of benzene, and even tripling the efficiency compared to the known method. If, in addition, acid chloride is used in an excess of 100 ct, the reaction can be completed within two hours. From the above-mentioned low reaction temperature, which can be, for example, -10°C to +20°C, it follows that the amount of impurities passing into 1,8-dihydroxy-10-acyl-9- anthrone produced is small. Purification is therefore a simple procedure compared to the corresponding procedure in known methods. Acetonitrile or 2-propanol can be used as a recrystallization solvent together with or instead of acetic acid. The compounds prepared according to the invention can be used, for example, in skin creams based on petroleum jelly or paraffin at a concentration of 0.5-5%, in sticks for skin care in a concentration of e.g. 2-8% and in jellies and film-forming solutions. The following examples explain the details of the invention. EXAMPLE I. Butyryl chloride in an amount of 207 ml (213 ml, 2.0 mol) was added over 2 hours in temperature below 0°C to a mixture that contained 2500 ml of toluene, 226 g (1.0 mol) of 1,8-dihydroxy-9-anthrone and 232 ml (214 g, 2.0 mol) of 2,6-dimethylpyridine. Mixture was stirred at a temperature below 0°C for a further two hours. The mixture was then warmed to +40°C, the 2,6-dimethylpyridine hydrochloride was filtered off, and most of the toluene was evaporated under reduced pressure. 2300 ml of isopropanol were added to the residue, the mixture was cooled to -10°C. The precipitate obtained after filtration was recrystallized from acetronitrile, obtaining 222 g of 1,8-dihydroxy-10-butyryl-9-anthrone, 75% of the theoretical yield. Example 11. The procedure was the same as in Example 1, except that xylene was used instead of toleene. The yield was the same as in example I, i.e. 75%. Example III. Propionyl chloride in an amount of 86.9 ml (92.5 g, 1 mol) was added over about 2 hours at a temperature below 0°C to a mixture that contained 1200 ml of toluene, 113 g (0.5 mol) of 1,8-dihydroxy-9 -anthron and 116ml (107g, 1 mol) 2,6-dimethylpyridine. Stirring was continued for a further two hours after the addition. The 1,8-dihydroxy-10-propionyl-9-anthrone obtained was separated as described in Example 1. The yield was 120 g, i.e. 82% of the theoretical yield. Example IV. Using 1,8-dihydroxy-9-anthrone and valeryl chloride in an excess of 100% and proceeding as in Example I, 1,8-dihydroxy-10-valeryl-9-anthrone was obtained with a yield of 53%. Patent claims 1. A method for preparing 1,8-dihydroxy-10-acyl-9-anthrone of formula 1, in which R is an alkyl group with 2-4 carbon atoms, by reacting 1,8-dihydroxy-9-anthrone of formula 2 with an acid chloride of the formula RCOC1, where R has the above-mentioned meaning, characterized in that 2,6-dimethylpyridine is used in the reaction mixture. 2. The method according to claim The process according to claim 1, characterized in that the solvent is toluene, xylene or chlorinated hydrocarbons such as dichloromethane or tetrachloroethane. 3. The method according to claim 1, characterized in that the acid chloride is used in an excess of 100%. 4. The method according to claim 1, characterized in that the reaction temperature is -10 to -1-20°C, the acid chloride is added within 2 hours, and stirring is continued for another two hours.141866 CO-R FORMULA 1 HO O OH WZCfR 2 PL PL PL PL

Claims (4)

1. Zastrzezenia patentowe 1. Sposób wytwarzania l,8-dwuhydroksy-10-acylo-9-antronu, o wzorze 1, w którym R ozna¬ cza grupe alkilowa o 2-4 atomach wegla, poprzez reakcje 1,8-dwuhydroksy-9-antronu o wzorze 2 z chlorkiem kwasowym o wzorze RCOC1, w którym R ma wyzej podane znaczenie, znamienny tym, ze w mieszaninie reakcyjnej stosuje sie 2,6-dwumetylopirydyne.1. Patent claims 1. Method of preparing 1,8-dihydroxy-10-acyl-9-anthrone, of formula 1, in which R is an alkyl group with 2-4 carbon atoms, by the reaction of 1,8-dihydroxy-9 -anthrone of formula 2 with an acid chloride of formula RCOC1, in which R has the above-mentioned meaning, characterized in that 2,6-dimethylpyridine is used in the reaction mixture. 2. Sposób wedlug zastrz. 1, znamienny tym, ze jako rozpuszczalnik stosuje sie toluen, ksylen albo chlorowane weglowodory takie jak dwuchlorometan albo czterochloroetan.2. The method according to claim The process according to claim 1, characterized in that the solvent is toluene, xylene or chlorinated hydrocarbons such as dichloromethane or tetrachloroethane. 3. Sposób wedlug zastrz. 1, znamienny tym, ze chlorek kwasowy stosuje sie w nadmiarze wynoszacym 100%.3. The method according to claim 1, characterized in that the acid chloride is used in an excess of 100%. 4. Sposób wedlug zastrz. 1, znamienny tym, ze stosuje sie temperature reakcji -10 do-l-20oC, chlorek kwasowy dodaje sie w ciagu 2 godzin, i mieszanie kontynuuje sie w ciagu nastepnych dwóch godzin.141866 CO-R WZÓR 1 HO O OH WZCfR 2 PL PL PL PL4. The method according to claim 1, characterized in that the reaction temperature is -10 to -1-20°C, the acid chloride is added within 2 hours, and stirring is continued for another two hours.141866 CO-R FORMULA 1 HO O OH WZCfR 2 PL PL PL PL
PL1984247724A 1983-05-18 1984-05-17 Method of obtaining 1,8-dihydroxy-10-ocyl-9-antrones PL141866B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI831739A FI66585C (en) 1983-05-18 1983-05-18 FOERFARANDE FOER FRAMSTAELLNING AV SAERSKILT VID BEHANDLING AVSORIASIS ANVAENDBARA 1,8-DIHYDROXI-10-ACYL-9-ANTRONER

Publications (2)

Publication Number Publication Date
PL247724A1 PL247724A1 (en) 1985-06-18
PL141866B1 true PL141866B1 (en) 1987-09-30

Family

ID=8517222

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1984247724A PL141866B1 (en) 1983-05-18 1984-05-17 Method of obtaining 1,8-dihydroxy-10-ocyl-9-antrones

Country Status (31)

Country Link
JP (1) JPS59212443A (en)
KR (1) KR840009059A (en)
AU (1) AU560079B2 (en)
BE (1) BE899334A (en)
CA (1) CA1212943A (en)
CH (1) CH659464A5 (en)
CS (1) CS256379B2 (en)
DD (1) DD223702A5 (en)
DE (1) DE3418382A1 (en)
DK (1) DK154207C (en)
ES (1) ES8505167A1 (en)
FI (1) FI66585C (en)
FR (1) FR2546162B1 (en)
GB (1) GB2140007B (en)
GR (1) GR79971B (en)
HU (1) HUT36076A (en)
IL (1) IL71446A (en)
IN (1) IN156115B (en)
IS (1) IS2902A7 (en)
IT (1) IT1173473B (en)
LU (1) LU85292A1 (en)
NL (1) NL8401074A (en)
NO (1) NO157099C (en)
NZ (1) NZ207592A (en)
PH (1) PH20038A (en)
PL (1) PL141866B1 (en)
PT (1) PT78603B (en)
SE (1) SE453827B (en)
SU (1) SU1240351A3 (en)
YU (1) YU81784A (en)
ZA (1) ZA842223B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492372A1 (en) * 1980-10-21 1982-04-23 Cird 1,8-DIHYDROXY-9-ANTHRONES SUBSTITUTED IN POSITION 10 AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS
FR2591222B1 (en) * 1985-12-11 1988-07-22 Cird MONO, DI AND TRI-ESTERS OF 1,8-DIHYDROXY PHENYL-10 ANTHRONE-9 OR ANTHRANOL-9, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS
US4843097A (en) * 1984-06-13 1989-06-27 Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics
FR2566772B1 (en) * 1984-06-29 1986-11-14 Cird DIACYLOXY-1,8 ACYL-10 ANTHRONES, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS
FR2580631B1 (en) * 1985-04-17 1987-05-29 Cird HYDROXY-1 ACYLOXY-8 ACYL-10 ANTHRONES, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS
DE69223723T2 (en) * 1991-10-04 1998-04-16 Fisher & Paykel humidifier
DE4231636A1 (en) * 1992-09-22 1994-03-24 Beiersdorf Ag New anthrone and anthracene derivatives substituted in the 10-position, processes for their preparation, pharmaceutical or cosmetic compositions containing these compounds and their use
US5426197A (en) * 1993-07-19 1995-06-20 Teva Pharmaceutical Industries, Ltd. 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI57743C (en) * 1979-03-29 1980-10-10 Orion Yhtymae Oy FREQUENCY REQUIREMENT FOR NYA 1,8-DIHYDROXI-10-ACYL-9-ANTRONER MOT PSORIASIS

Also Published As

Publication number Publication date
BE899334A (en) 1984-07-31
IT8420213A0 (en) 1984-03-23
PT78603A (en) 1984-06-01
SE8402649D0 (en) 1984-05-16
GR79971B (en) 1984-10-31
IS2902A7 (en) 1984-06-07
NO841965L (en) 1984-11-19
PH20038A (en) 1986-09-04
NZ207592A (en) 1986-11-12
IL71446A0 (en) 1984-07-31
NO157099C (en) 1988-01-20
YU81784A (en) 1986-10-31
CA1212943A (en) 1986-10-21
FI831739A0 (en) 1983-05-18
LU85292A1 (en) 1984-10-26
ES531760A0 (en) 1985-05-16
SE453827B (en) 1988-03-07
SU1240351A3 (en) 1986-06-23
ZA842223B (en) 1984-11-28
GB2140007A (en) 1984-11-21
DK154207C (en) 1989-03-13
PL247724A1 (en) 1985-06-18
CS256379B2 (en) 1988-04-15
DD223702A5 (en) 1985-06-19
KR840009059A (en) 1984-12-24
JPS59212443A (en) 1984-12-01
GB8408666D0 (en) 1984-05-16
FR2546162B1 (en) 1987-01-30
NO157099B (en) 1987-10-12
IL71446A (en) 1987-01-30
HUT36076A (en) 1985-08-28
AU560079B2 (en) 1987-03-26
DK154207B (en) 1988-10-24
DK173584A (en) 1984-11-19
DK173584D0 (en) 1984-03-30
CH659464A5 (en) 1987-01-30
PT78603B (en) 1986-06-26
GB2140007B (en) 1986-04-09
FR2546162A1 (en) 1984-11-23
IT1173473B (en) 1987-06-24
DE3418382A1 (en) 1984-11-22
SE8402649L (en) 1984-11-19
CS291184A2 (en) 1987-08-13
ES8505167A1 (en) 1985-05-16
AU2599884A (en) 1984-11-22
FI66585B (en) 1984-07-31
NL8401074A (en) 1984-12-17
IN156115B (en) 1985-05-18
FI66585C (en) 1984-11-12

Similar Documents

Publication Publication Date Title
DE69131636T2 (en) (6,7-substituted-8-alkoxy-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid-03.04) -bis (acyloxy-0) -borates and their salts and methods for their preparation
DE2943498A1 (en) METHOD FOR PRODUCING 3-AMINO-1-HYDROXYPROPAN-1,1-DIPHOSPHONIC ACID
PL141866B1 (en) Method of obtaining 1,8-dihydroxy-10-ocyl-9-antrones
DE2202689A1 (en) New intermediate products of vitamin A synthesis
DE3336225C2 (en)
DE1230031B (en) Process for the preparation of derivatives of naphthalene-1, 4, 5, 8-tetracarboxylic acid diimide
DE1176660B (en) Process for the preparation of triaryl-substituted imidazolinones-4 (5)
US4412075A (en) Process for the preparation of quinolin-4-ones
US4450274A (en) Preparation of ethambutol-diisoniazide methane sulfonic acid salt
EP0134934B1 (en) 2-keto-sulphon amides and process for their production
DE3135728C2 (en) Process for the preparation of apovincamic acid esters
DE1801205A1 (en) Aminoalkylated thioether of 2-mercaptoindoles and process for their preparation
KR890001851B1 (en) Process for the preparation of amine alkanolester
EP0018732B1 (en) An alpha-methyl-4(2'-thienyl-carbonyl)phenyl acetic acid derivative, process for its preparation and its pharmaceutical use
AT200579B (en) Process for the preparation of the new 5-dibenzo [b, f] azepines
CS200213B2 (en) Method of preparing indazole derivatives
AT268323B (en) Process for the preparation of new 3,1-benzothiazine derivatives and their salts
EP0087656B1 (en) Process for the preparation of 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indolylacetoxy-acetic acid
Horn RESEARCHES ON PYRIMIDINES. XCI. ALKYLATION OF 2-MERCAPTO-PYRIMIDINES.
DE2361266A1 (en) METHOD FOR PREPARING DESACETOXY-CEPHALOSPORANIC ACID COMPOUNDS
KR810000854B1 (en) Process for the preparation of benzamides
AT268300B (en) Process for the preparation of new 3,1-benzothiazine derivatives and their salts
RU1796619C (en) N-phenacetyl-n-ethyldithiocarbamine acid as intermediate product in thiazolium salts synthesis and method for thiazolium salts production
DE2252323B2 (en) 3,6-Dialkyl-23-dihydro-2,9-dioxo-6H, 9H-thiazolo [5,4-fJ quinoline-e-carbonyl derivatives, processes for their preparation and their use as bactericides
SU437284A1 (en) Method for preparing indeno-pyridine derivatives